B. Sharda Pharma Pellets Private Limited

B. Sharda Pharma Pellets Private Limited - pharma in Palanpur, Gujarat, India. FY 2026 financials & compliance.
CIN U24231GJ2020PTC113344 Incorporated 31 March 2020 ROC Ahmedabad HQ Palanpur, Gujarat, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹20.12 Cr
▲ 37% YoY
Net profit · FY 2024
₹40.49 Lakh
Net margin 2%
EBITDA · FY 2024
₹1.18 Cr
EBITDA margin 5.9%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹8.11 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About B. Sharda Pharma Pellets Private Limited

Data last updated:

B. Sharda Pharma Pellets Private Limited is a private limited company based in Palanpur, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2020PTC113344. Its GSTIN is 24AAICB9744R1ZV (Gujarat).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Priyank Mukeshbhai Kela and Saurav Gautambhai Kela.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Appu House Mandora Vadi Laxman Tekri Mansarovar Road, Palanpur, Gujarat, India – 385001.

As per the financials filed for FY 2024, the company reported a revenue of ₹20.12 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹40.49 Lakh (net margin 2%) and EBITDA of ₹1.18 Cr (EBITDA margin 5.9%).

As per MCA filings, the company has open charges of ₹8.11 Cr on record.

B. Sharda Pharma Pellets Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-04-0000086).

Company details

CIN U24231GJ2020PTC113344
Registration Number 113344
Incorporation Date 31 March 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Small
Udyam Registration UDYAM-GJ-04-0000086

Recognitions & Rankings of B. Sharda Pharma Pellets

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-04-0000086

Contact details

B. Sharda Pharma Pellets Private Limited's registered office is in Palanpur, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Appu House Mandora Vadi Laxman Tekri Mansarovar Road, Palanpur, Gujarat, India – 385001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of B. Sharda Pharma Pellets Private Limited, buy the company report.

Comprehensive company report
B. Sharda Pharma Pellets Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of B. Sharda Pharma Pellets is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of B. Sharda Pharma Pellets Private Limited, buy the company report.

Financials of B. Sharda Pharma Pellets Private Limited

FY 2024 filings available

B. Sharda Pharma Pellets Private Limited reported revenue of ₹20.12 Cr (up 37% YoY) for FY 2024.

Revenue · FY 2024
₹20.12 Cr ▲ 37%
Net profit · FY 2024
₹40.49 Lakh margin 2%
EBITDA · FY 2024
₹1.18 Cr margin 5.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 37%
EBITDA CAGR growth
1 year
▲ 72%
3 years · compounded
▲ 335%

Revenue rose 37% in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹20.12 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.18 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹40.49 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.9%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of B. Sharda Pharma Pellets Private Limited, buy the company report.

Board of directors of B. Sharda Pharma Pellets Private Limited

B. Sharda Pharma Pellets has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Priyank Mukeshbhai KelaDirector31 Mar 20206 Years 7 MonthsCurrent
Saurav Gautambhai KelaDirector31 Mar 20206 Years 7 MonthsCurrent

Peer comparison

B. Sharda Pharma Pellets Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Scikem Pharmaceuticals Private Limited₹20.26 Cr (FY 2024)-43.0%Hydertabad, Telangana, India
VSN Laboratories Private Limited₹20.26 Cr (FY 2023)-7.0%Hyderabad, Telangana, India
Ohad Pharmaceuticals Private Limited₹20.22 Cr (FY 2025)6.0%Bharuch, Gujarat, India
Biocenna Healthcare Private Limited₹20.13 Cr (FY 2025)125.0%Deoband, Uttar Pradesh, India
B. Sharda Pharma Pellets Private Limitedthis company₹20.12 Cr (FY 2024)₹40.49 Lakh2%37.0%Palanpur, Gujarat, India
RND Laboratories Private Limited₹20.09 Cr (FY 2025)1.0%Bhubaneswar, Odisha, India
Yash Medicare Private Limited₹20.07 Cr (FY 2025)-22.0%Sabarkantha, Gujarat, India

To see the full peer comparison of B. Sharda Pharma Pellets Private Limited, buy the company report.

Auditor

B. Sharda Pharma Pellets Private Limited is audited by R. CHOUDHARY & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R. CHOUDHARY & ASSOCIATESFY 2024101928W

Shareholding

The shareholding of B. Sharda Pharma Pellets Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of B. Sharda Pharma Pellets Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.11 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹4.00 Cr
Sidbi₹2.60 Cr
Others₹1.51 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Sep 2025101176685Others₹1.51 CrOpen
05 Dec 2024101018005Sidbi₹2.6 CrOpen
05 May 2021100447548Hdfc Bank Limited₹4 CrOpen

To see the full charge records of B. Sharda Pharma Pellets Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for B. Sharda Pharma Pellets Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

B. Sharda Pharma Pellets Private Limited has 1 active EPFO establishment as of Mar 22, 2024.

Active EPFO establishments
1

GST

B. Sharda Pharma Pellets has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAICB9744R1ZVGujaratActive29 Oct 2020

To see the full GST registrations and return filing status of B. Sharda Pharma Pellets Private Limited, buy the company report.

Recent activity

B. Sharda Pharma Pellets Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Priyank Mukeshbhai Kela was appointed as Director on 31 Mar 2020.

Charges
A charge with Others amounted to Rs. 151.00 Lakh with Charge ID 101176685 was registered on 20 Sep 2025.
Charges
A charge with Sidbi amounted to Rs. 260.00 Lakh with Charge ID 101018005 was registered on 05 Dec 2024.
AGM
B. Sharda Pharma Pellets Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
B. Sharda Pharma Pellets Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 400.00 Lakh registered on 05 May 2021 with Charge ID 100447548 was modified on 12 Sep 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 400.00 Lakh with Charge ID 100447548 was registered on 05 May 2021.
Appointed
Priyank Mukeshbhai Kela was appointed as Director.
Appointed
Saurav Gautambhai Kela was appointed as Director.
Incorporation
31 Mar 2020
B. Sharda Pharma Pellets Private Limited was registered on 31 Mar 2020 with Roc Ahmedabad & aged 6 years 7 months as per MCA records.

Frequently asked questions

B. Sharda Pharma Pellets is an active private limited company based in Palanpur, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2020 (6+ years old) and is registered under CIN U24231GJ2020PTC113344.

B. Sharda Pharma Pellets has 2 current directors:

The latest financial statements of B. Sharda Pharma Pellets on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.

The GSTIN of B. Sharda Pharma Pellets is 24AAICB9744R1ZV, registered in Gujarat.

The CIN (Corporate Identification Number) of B. Sharda Pharma Pellets is U24231GJ2020PTC113344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

B. Sharda Pharma Pellets was incorporated on 31 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of B. Sharda Pharma Pellets by revenue are Scikem Pharmaceuticals Private Limited, VSN Laboratories Private Limited, Ohad Pharmaceuticals Private Limited, Biocenna Healthcare Private Limited, RND Laboratories Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Priyank Mukeshbhai Kela was appointed as Director on 31 Mar 2020. Saurav Gautambhai Kela was appointed as Director on 31 Mar 2020.

Yes, B. Sharda Pharma Pellets is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-04-0000086).

The registered office of B. Sharda Pharma Pellets is at Appu House Mandora Vadi Laxman Tekri Mansarovar Road, Palanpur, Gujarat, India – 385001.

B. Sharda Pharma Pellets operates in the pharma industry, in the drug formulation and development segment.